← Open Payments lookup

LARIDER RUFFIN: Open Payments

NPI 1861785099 · LINWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$278 in 11 payments from 6 companies in 2025. Trend: 2023 $39 · 2024 $151 · 2025 $278

Food & beverage: $248Long term medical supply or device loan: $30
CompanyPaymentsAmount
Novo Nordisk Inc1$99
E.R. Squibb & Sons, L.L.C.5$82
Teva Pharmaceuticals USA, Inc.2$31
Abbott Laboratories1$30
ABBVIE INC.1$20
Otsuka America Pharmaceutical, Inc.1$17

Products named: Ozempic, COBENFY, AUSTEDO XR, FREESTYLE INSULINX, VRAYLAR, REXULTI.

Industry payments across NJ — which companies pay providers there.